Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Shanghai Menon Animal Nutrition Technology
301156
5
Nanjing Railway New Technology
301016
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 27.03%-43.47M | 9.18%-13.79M | 54.13%-5.74M | -43.93%-12.09M | 49.53%-11.85M | 10.56%-59.57M | 23.47%-15.19M | -44.78%-12.51M | 62.83%-8.4M | -51.23%-23.48M |
Net income from continuing operations | -11.06%-81.94M | 52.00%-16.06M | -64.59%-20.52M | -42.96%-20.17M | -83.26%-25.19M | 56.84%-73.78M | 69.46%-33.46M | 55.31%-12.47M | -13.91%-14.11M | 34.90%-13.75M |
Operating gains losses | -236.32%-2.05M | -411.32%-813K | -20,480.00%-1.03M | -156.85%-527K | -57.47%316K | -97.78%1.51M | -100.23%-159K | 98.45%-5K | 116.28%927K | -85.66%743K |
Depreciation and amortization | 0.56%362K | -16.33%82K | -4.60%83K | 28.74%112K | -3.41%85K | -13.88%360K | -17.65%98K | -20.91%87K | -7.45%87K | -7.37%88K |
Other non cash items | 217.23%2.52M | 97.48%942K | --601K | --502K | --477K | --795K | --477K | ---- | ---- | ---- |
Change In working capital | 1,625.71%12.4M | -126.64%-4.05M | 396.77%8.82M | -4.21%2.07M | 136.59%5.57M | -105.03%-813K | -12.00%15.21M | -118.66%-2.97M | 119.80%2.16M | -148.44%-15.22M |
-Change in receivables | -83.02%127K | -77.49%707K | 60.97%-1.36M | -51.35%757K | 105.45%25K | -22.08%748K | 31.64%3.14M | -935.61%-3.49M | 191.10%1.56M | -174.15%-459K |
-Change in payables and accrued expense | 886.48%12.28M | -139.42%-4.76M | 1,861.27%10.18M | 116.83%1.31M | 137.56%5.54M | -110.27%-1.56M | -18.99%12.07M | -96.81%519K | 106.58%606K | -118.83%-14.76M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 27.03%-43.47M | 9.18%-13.79M | 54.13%-5.74M | -43.93%-12.09M | 49.53%-11.85M | 10.56%-59.57M | 23.47%-15.19M | -44.78%-12.51M | 62.83%-8.4M | -51.23%-23.48M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 10.90%-515K | 87.59%-50K | 50.00%-50K | 0.00%-75K | -340K | 50.56%-578K | -91.90%-403K | 80.28%-100K | 69.01%-75K | 0 |
Net PPE purchase and sale | 10.90%-515K | 87.59%-50K | 50.00%-50K | 0.00%-75K | ---340K | 50.56%-578K | -91.90%-403K | 80.28%-100K | 69.01%-75K | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 10.90%-515K | 87.59%-50K | 50.00%-50K | 0.00%-75K | ---340K | 50.56%-578K | -91.90%-403K | 80.28%-100K | 69.01%-75K | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 102.76%40.69M | 11,682.00%17.37M | -62.83%5.63M | 10,835.44%8.64M | 80.96%9.05M | -32.49%20.07M | -188.46%-150K | -49.18%15.14M | 16.18%79K | 6,510.26%5M |
Net issuance payments of debt | --11.78M | --2.6M | --3.3M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
Net common stock issuance | 80.32%28.77M | 7,350.00%14.9M | -85.24%2.32M | 8,386.67%2.55M | --9M | -47.52%15.95M | 20,100.00%200K | -48.28%15.72M | --30K | --0 |
Cash dividends paid | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
Proceeds from stock option exercised by employees | 70.17%502K | -71.70%15K | -72.02%54K | 395.92%243K | --190K | 55.26%295K | -8.62%53K | 201.56%193K | --49K | --0 |
Net other financing activities | -109.35%-357K | 46.65%-215K | --0 | --0 | -102.84%-142K | 540.37%3.82M | -269.72%-403K | -14.56%-779K | --0 | 6,510.26%5M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 102.76%40.69M | 11,682.00%17.37M | -62.83%5.63M | 10,835.44%8.64M | 80.96%9.05M | -32.49%20.07M | -188.46%-150K | -49.18%15.14M | 16.18%79K | 6,510.26%5M |
Net cash flow | ||||||||||
Beginning cash position | -85.40%6.84M | -98.40%360K | -97.63%474K | -85.95%3.99M | -85.40%6.84M | -44.77%46.88M | -66.27%22.55M | -56.73%20.01M | -58.85%28.41M | -44.77%46.88M |
Current changes in cash | 91.77%-3.3M | 122.44%3.53M | -106.32%-160K | 58.01%-3.53M | 82.99%-3.14M | -5.35%-40.09M | 21.72%-15.74M | -87.73%2.53M | 63.13%-8.4M | -16.86%-18.48M |
Effect of exchange rate changes | -227.45%-65K | -1,625.93%-412K | 557.14%46K | 366.67%8K | 1,365.00%293K | -3.77%51K | -75.23%27K | 125.93%7K | 85.71%-3K | 350.00%20K |
End cash Position | -49.14%3.48M | -49.14%3.48M | -98.40%360K | -97.63%474K | -85.95%3.99M | -85.40%6.84M | -85.40%6.84M | -66.27%22.55M | -56.73%20.01M | -58.85%28.41M |
Free cash flow | 26.88%-43.98M | 11.21%-13.84M | 54.10%-5.79M | -43.54%-12.16M | 48.08%-12.19M | 11.25%-60.15M | 22.27%-15.59M | -37.85%-12.61M | 62.89%-8.47M | -49.21%-23.48M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |